Blood thinner choice after cesarean section to prevent blood clots
Treatments studied
Part of Heart & circulation clinical trials.
This study compares two blood-thinner medicines given after a C-section to see which one works better at preventing dangerous blood clots. It may help women who are at higher risk for clots rest easier right after delivery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You speak Hebrew
- You are between 18 and 50 years old
- You are having a planned C-section at Wolfson Medical Center
- You have at least 2 risk factors for blood clots (such as being over 35, having a high BMI, or having a long labor)
- You do not have any medical conditions that make blood thinners unsafe for you
- You weigh between 50 and 100 kg (about 110 to 220 pounds)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if taking aspirin after delivery helps prevent dangerous blood clots in women with certain risk factors. It's for new mothers who have a clotting disorder, were on bed rest, or have multiple other risk factors like high weight or preeclampsia.
This study looks at how a blood thinner called rivaroxaban enters breast milk after delivery. It may help women who need this medication while breastfeeding.
This trial compares two blood-thinning medicines (apixaban and enoxaparin) to prevent dangerous blood clots after childbirth. If you are at higher risk for clots but not breastfeeding, you may be able to take part.
This study tests whether giving a short course of a daily blood-thinning injection (enoxaparin) after childbirth can safely prevent blood clots in women at intermediate risk. If you qualify, you would receive the injection or a placebo (inactive shot) for up to 5 days while in the hospital.
This trial is testing a short course of a low-dose blood thinner (heparin) to prevent dangerous blood clots in the legs or lungs after childbirth. It is for women who have certain risk factors that make clots more likely.
This trial studies whether tranexamic acid, a medicine that helps blood clot, can prevent postpartum hemorrhage (heavy bleeding after delivery) in people having a planned C-section or likely vaginal delivery after 34 weeks. It may help lower the risk of dangerous bleeding around the time of birth.
Hear when a new Postpartum Period trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.